128 related articles for article (PubMed ID: 37679892)
1. Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group.
Calmels M; Labiad C; Lelong B; Lefevre JH; Tuech JJ; Benoist S; Mège D; Denost Q; Panis Y
Colorectal Dis; 2023 Oct; 25(10):1973-1980. PubMed ID: 37679892
[TBL] [Abstract][Full Text] [Related]
2. Local excision after neoadjuvant chemoradiotherapy versus total mesorectal excision: a case-matched study in 110 selected high-risk patients with rectal cancer.
Calmels M; Collard MK; Cazelles A; Frontali A; Maggiori L; Panis Y
Colorectal Dis; 2020 Dec; 22(12):1999-2007. PubMed ID: 32813899
[TBL] [Abstract][Full Text] [Related]
3. Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?
Debove C; Guedj N; Tribillon E; Maggiori L; Zappa M; Panis Y
Int J Colorectal Dis; 2016 Apr; 31(4):853-60. PubMed ID: 26951185
[TBL] [Abstract][Full Text] [Related]
4. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
[TBL] [Abstract][Full Text] [Related]
5. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).
Serra-Aracil X; Pericay C; Badia-Closa J; Golda T; Biondo S; Hernández P; Targarona E; Borda-Arrizabalaga N; Reina A; Delgado S; Vallribera F; Caro A; Gallego-Plazas J; Pascual M; Álvarez-Laso C; Guadalajara-Labajo HG; Mora-Lopez L
Ann Oncol; 2023 Jan; 34(1):78-90. PubMed ID: 36220461
[TBL] [Abstract][Full Text] [Related]
6. Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer.
Coco C; Delrio P; Rega D; Amodio LE; Pucciarelli S; Spolverato G; Belluco C; Lauretta A; Poggioli G; Rocco G; Bianco F; Marsanic P; Sica G; Tondolo V; Rizzo G;
Colorectal Dis; 2024 Feb; 26(2):281-289. PubMed ID: 38131642
[TBL] [Abstract][Full Text] [Related]
7. Local excision for ypT2 rectal cancer following preoperative chemoradiation therapy: it should not be justified.
Yang KM; Lim SB; Lee JL; Kim CW; Yoon YS; Park IJ; Yu CS; Kim JC
Int J Colorectal Dis; 2018 Apr; 33(4):487-491. PubMed ID: 29468352
[TBL] [Abstract][Full Text] [Related]
8. Early and late morbidity of local excision after chemoradiotherapy for rectal cancer.
Teste B; Rouanet P; Tuech JJ; Valverde A; Lelong B; Rivoire M; Faucheron JL; Jafari M; Portier G; Meunier B; Sielezneff I; Prudhomme M; Marchal F; Dubois A; Capdepont M; Denost Q; Rullier E
BJS Open; 2021 May; 5(3):. PubMed ID: 34097005
[TBL] [Abstract][Full Text] [Related]
9. Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials.
Lynch P; Ryan OK; Donnelly M; Ryan ÉJ; Davey MG; Reynolds IS; Creavin B; Hanly A; Kennelly R; Martin ST; Winter DC
Int J Colorectal Dis; 2023 Nov; 38(1):263. PubMed ID: 37924372
[TBL] [Abstract][Full Text] [Related]
10. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
[TBL] [Abstract][Full Text] [Related]
11. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
[TBL] [Abstract][Full Text] [Related]
12. Chemoradiation and Local Excision Versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes From 2 Prospective Studies.
Lynn PB; Van der Valk MJM; Claassen YHM; Shi Q; Widmar M; Bastiaannet E; Van de Velde CJH; Garcia-Aguilar J
Ann Surg; 2023 Jan; 277(1):e96-e102. PubMed ID: 34225302
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
[TBL] [Abstract][Full Text] [Related]
14. Transanal local excision versus intersphincteric resection for low rectal cancer with stage ypT0-1ycN0 after neoadjuvant chemoradiotherapy: an inverse probability weighting analysis for oncological and functional outcomes.
Pan H; Gao Y; Ruan H; Chi P; Huang Y; Huang S
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17383-17394. PubMed ID: 37843558
[TBL] [Abstract][Full Text] [Related]
15. Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.
Marchegiani F; Palatucci V; Capelli G; Guerrieri M; Belluco C; Rega D; Morpurgo E; Coco C; Restivo A; De Franciscis S; Aschele C; Perin A; Bonomo M; Muratore A; Spinelli A; Ramuscello S; Bergamo F; Montesi G; Spolverato G; Del Bianco P; Gambacorta MA; Delrio P; Pucciarelli S
Ann Surg Oncol; 2022 Mar; 29(3):1880-1889. PubMed ID: 34855063
[TBL] [Abstract][Full Text] [Related]
16. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
[TBL] [Abstract][Full Text] [Related]
17. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
18. Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial.
Lee JL; Lim SB; Yu CS; Park IJ; Yoon YS; Kim CW; Park SH; Lee JS; Hong YS; Kim SY; Kim JE; Kim JH; Park JH; Kim J; Han M
BMC Cancer; 2019 Apr; 19(1):404. PubMed ID: 31035949
[TBL] [Abstract][Full Text] [Related]
19. Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Score-Matched Analysis.
Yamaguchi T; Akiyoshi T; Fukunaga Y; Sakamoto T; Mukai T; Hiyoshi Y; Nagasaki T; Taguchi S; Chino A; Shinozaki E; Yamaguchi K; Konishi T
Ann Surg Oncol; 2023 Aug; 30(8):4716-4724. PubMed ID: 37032405
[TBL] [Abstract][Full Text] [Related]
20. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.
Zinicola R; Nascimbeni R; Cirocchi R; Gagliardi G; Cracco N; Giuffrida M; Pedrazzi G; Binda GA
Tech Coloproctol; 2021 Sep; 25(9):997-1010. PubMed ID: 34173121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
